Google
LMAT 株価分析 — Lemaitre Vascular Inc (Healthcare >> Medical Instruments & Supplies)
LMAT に関するよくある質問
LMATのPER（株価収益率）は？
Lemaitre Vascular Inc（LMAT）は現在PER 37.42倍で取引されています。
LMATのROE（自己資本利益率）は？
Lemaitre Vascular IncのROEは15.35%です。
LMATの配当利回りは？
Lemaitre Vascular Incの配当利回りは0.82%です。
LMATの品質スコア（Quality Score）は？
当社のAIはLMATの総合財務品質を100点中100点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
LMATは今が買い時ですか？
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
LMATはどのセクターに属しますか？
Lemaitre Vascular IncはHealthcare >> Medical Instruments & Suppliesセクターに分類されます（NASDAQ市場）
LMAT AI Analysis Summary
Our AI summary for LMAT: Lemaitre Vascular Inc (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 37.42, ROE of 15.35%, a dividend yield of 0.82%. Its financial Quality Score stands at 100/100 — fundamentals stronger than most of the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 101.32
Price
-0.87
(-0.85%)
Day Change
|
|
|---|
LMAT, ファンダメンタルスコアはexcellent ( ファンダメンタル = 100) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Excellent
- Reason
-
Company financial health is Excellent from almost all quality indicators
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is very good , ...
| Deepscope 分析 |
|
52% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
1532
|
| Magic Formula Rank by ROE |
1532
|
| Magic Formula Rank by ROIC |
1176
|
| Price | 101.32 |
| PBV / Sector |
5.74 / 3.37
|
| Earning Per Share | 2.71 |
| PE / Sector |
37.42 / 44.25
|
| PEG or PE/Growth / Sector |
0.95 / -1.35
|
| Average 1M Daily Value |
27.23 M
GREAT
|
| Average 1W Daily Value |
26.43 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
81% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:07 |
| Symbol | LMAT |
| Name | LEMAITRE VASCULAR INC |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 22.85 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,335.12 / 16,159.14 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 63 Second Avenue, Burlington, MA, United States, 01803
Phone: 781 221 2266
Website: https://www.lemaitre.com
Employees: 646
Description: LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
